Skip to main content
. 2020 Nov 5;8:578036. doi: 10.3389/fcell.2020.578036

TABLE 1.

Gene functional classification clusters of DEGs between D10 isorhamnetin-treated and D0 control hAECs and D10 isorhamnetin-treated and D10 control hAECs.

Clusters and top enriched GO in cluster Enrichment score Genes in cluster
D10 isorhamnetin treated vs. D0 control
Cluster 1 cilium assembly (GO:0060271), microtubule cytoskeleton organization (GO:0000226), mitotic cell cycle (GO:0000278), cell division (GO:0051301), protein binding (GO:0005515), microtubule binding (GO:0008017) 13.63 SPICE1, C1orf116, CEP95, BBOF1, SPATA18, CEP162, CEP55, CEP126, MAP7D3, KIAA0753, FILIP1L, CCDC113, MISP, MTUS2, MZT2A, NREP, RAB3IP, CEP68, CAMSAP2, ZNF365
Cluster 2 cell division (GO:0051301), mitotic cell cycle (GO:0000278), cell population proliferation (GO:0008283), regulation of mitotic spindle organization (GO:0060236), metaphase plate congression (GO:0051310), microtubule binding (GO:0008017), protein kinase binding (GO:0019901), protein binding (GO:0005515) 9.37 TPX2, TACC3, SPICE1, CDCA3, PRC1, MISP, MAPRE2, FAM83D, CCNG2, MAP7D3
Cluster 3 cell-cell adhesion (GO:0098609), cell differentiation (GO:0030154), cell junction assembly (GO:0034329), transforming growth factor beta receptor signaling pathway (GO:0007179), zinc ion binding (GO:0008270), cadherin binding involved in cell-cell adhesion (GO:0098641) 9.17 FBLIM1, TGFB1I1, PDLIM5, ZYX, PDLIM2, AJUBA, CRIP1, ZNF185, LIMS2, C11orf54, FHL2, FHL1, LMO7, LIMA1, LMCD1, CSRP2, CSRP1, PDLIM1, TES, PRICKLE2, PXN, PDLIM7
Cluster 4 apical constriction (GO:0003383), regulation of cell shape (GO:0008360), integrin-mediated signaling pathway (GO:0007229), transforming growth factor beta receptor signaling pathway (GO:0007179), protein binding (GO:0005515), structural constituent of cytoskeleton (GO:0005200) 7.54 FERMT1, RAPH1, FRMD6, FERMT2
Cluster 5 protein ubiquitination (GO:0016567), transcription, DNA-templated (GO:0006351) 7.51 FILIP1L, IRF2BP2, CRBN, PRR11

D10 isorhamnetin treated vs. D10 control

Cluster 1 sequestering of TGFβ in ECM (GO:0035583), positive regulation of cell substrate adhesion (GO:0010811), cell-matrix adhesion (GO:0007160), extracellular matrix organization (GO:0030198), calcium ion binding (GO:0005509), extracellular matrix structural constituent (GO:0005201) 7.70 THBS3, SUSD1, EFEMP2, FBN2, FBLN2, NPNT, LTBP2, LTBP1, DNER
Cluster 2 O-glycan processing (GO:0016266), G protein-coupled receptor signaling pathway (GO:0007186), cell surface receptor signaling pathway (GO:0007166), cell migration (GO:0016477), cell adhesion (GO:0007155), G protein-coupled receptor activity (GO:0004930) 7.42 LGR5, UPK3BL, TMEM40, ALPK2, LY6G6C, GPR85, MYRFL, CLEC7A, TNFRSF25, KLK5, B3GNT3, GPR1, IGFBP7, VTCN1, PSG5, MFAP3L, KERA, BAMBI, TMPRSS11A, MMP23B, SLC39A4, APCDD1, MEST, SLC1A6, CADM1, LRRC32, C1QTNF6, KCNE4, SMCO3, ADGRF5, TRBC1, ADGRF4, SEMA6D, SCARA3, SIGLEC5, B3GNT2, NTM, PAQR5, OPN3, IER3, TSPAN1, GPR155, CD248, RARRES1, IGFBPL1, ADGRF1, GALNT2, ABCG2, DNER, GALNT5, PRRG4, CSF2RB, FAM198B, AMIGO2, GPR37, SUSD1, TMPRSS11B, TMPRSS11E, ACKR3, CXADR, PTPRM, S1PR1
Cluster 3 cell-matrix adhesion (GO:0007160), anatomical structure morphogenesis (GO:0009653), protein binding (GO:0005515), co-receptor activity involved in Wnt signaling pathway, planar cell polarity pathway (GO:1904929) 7.25 NTM, LYPD5, GPC4, CPM, MSLN, LY6G6C
Cluster 4 extracellular matrix organization (GO:0030198), collagen catabolic process (GO:0030574), extracellular matrix structural constituent (GO:0005201) 4.80 EMILIN1, COL1A2, COL1A1, COL4A6
Cluster 5 positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531), positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731), cytokine-mediated signaling pathway (GO:0019221), cytokine receptor activity (GO:0004896) 4.09 CSF2RB, GHR, IL6R, IL4R